HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 214 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,429 | +805.5% | 159,761 | +712.0% | 0.02% | +433.3% |
| Q2 2023 | $710 | -5.5% | 19,674 | 0.0% | 0.00% | -25.0% |
| Q1 2023 | $751 | -32.9% | 19,674 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $1,119 | -99.9% | 19,674 | 0.0% | 0.01% | +50.0% |
| Q3 2022 | $778,000 | -10.2% | 19,674 | 0.0% | 0.00% | -20.0% |
| Q2 2022 | $866,000 | +10.3% | 19,674 | 0.0% | 0.01% | +25.0% |
| Q1 2022 | $785,000 | -11.9% | 19,674 | -11.2% | 0.00% | 0.0% |
| Q4 2021 | $891,000 | -1.1% | 22,149 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $901,000 | -10.4% | 22,149 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,006,000 | +9.0% | 22,149 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $923,000 | -2.4% | 22,149 | 0.0% | 0.00% | -20.0% |
| Q4 2020 | $946,000 | +34.8% | 22,149 | -17.1% | 0.01% | +25.0% |
| Q3 2020 | $702,000 | -2.0% | 26,722 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $716,000 | +48.9% | 26,722 | 0.0% | 0.00% | +33.3% |
| Q1 2020 | $481,000 | +1.5% | 26,722 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $474,000 | +14.5% | 26,722 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $414,000 | -9.8% | 26,722 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $459,000 | +6.7% | 26,722 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $430,000 | +10.0% | 26,722 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $391,000 | -19.5% | 26,722 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $486,000 | +7.8% | 26,722 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $451,000 | -13.8% | 26,722 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $523,000 | -7.8% | 26,722 | -4.6% | 0.00% | -25.0% |
| Q4 2017 | $567,000 | +16.7% | 27,999 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $486,000 | +35.4% | 27,999 | 0.0% | 0.00% | +33.3% |
| Q2 2017 | $359,000 | -1.1% | 27,999 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $363,000 | +31.0% | 27,999 | -0.0% | 0.00% | +50.0% |
| Q4 2016 | $277,000 | -18.0% | 28,013 | 0.0% | 0.00% | -33.3% |
| Q3 2016 | $338,000 | +39.7% | 28,013 | 0.0% | 0.00% | +50.0% |
| Q2 2016 | $242,000 | -8.7% | 28,013 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $265,000 | -44.8% | 28,013 | +1.0% | 0.00% | -50.0% |
| Q4 2015 | $480,000 | +165.2% | 27,723 | +106.2% | 0.00% | +100.0% |
| Q3 2015 | $181,000 | -40.5% | 13,444 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $304,000 | – | 13,444 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
| First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
| SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
| DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
| Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
| Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
| Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
| Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |